Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Perspective Therapeutics (CATX) FCF Margin (2016 - 2023)

Perspective Therapeutics' FCF Margin history spans 14 years, with the latest figure at 185.58% for Q4 2023.

  • On a quarterly basis, FCF Margin changed N/A to 185.58% in Q4 2023 year-over-year; TTM through Dec 2023 was 6196.57%, a N/A change, with the full-year FY2023 number at 2648.88%, changed N/A from a year prior.
  • FCF Margin hit 185.58% in Q4 2023 for Perspective Therapeutics, up from 506.86% in the prior quarter.
  • Over the last five years, FCF Margin for CATX hit a ceiling of 185.58% in Q4 2023 and a floor of 542.3% in Q1 2023.
  • Historically, FCF Margin has averaged 116.0% across 5 years, with a median of 52.88% in 2019.
  • Biggest five-year swings in FCF Margin: soared 13302bps in 2021 and later tumbled -49247bps in 2023.
  • Tracing CATX's FCF Margin over 5 years: stood at 62.74% in 2019, then surged by 45bps to 34.76% in 2020, then skyrocketed by 383bps to 98.26% in 2021, then crashed by -210bps to 107.92% in 2022, then surged by 272bps to 185.58% in 2023.
  • Business Quant data shows FCF Margin for CATX at 185.58% in Q4 2023, 506.86% in Q3 2023, and 525.93% in Q2 2023.